Latest from Healthcare

Olympian: Sir Chris Hoy is an official brand ambassador for Sport in Science

Sports nutrition business used by Sir Chris Hoy joins London's junior exchange

Science in Sport is targeting its share of a reported £19.6 billion global market in 2010 by securing a stock market listing.

Willowbrook Healthcare now employs 938 staff and has 13 freehold homes

Graphite Capital closes third healthcare exit with same management team

Private equity firm Graphite Capital has followed up on its recent investment in the Hawksmoor chain of restaurants by exiting its interest in Willowbrook Healthcare.

The Biomedical Catalyst was designed to target the 'valley of death' funding gap

Spending review outlines raft of new healthcare sector business investments

The Biomedical Catalyst is allocating £25.9 million as part of a new support package for businesses and academic projects in the health industry.

Clinical research: The inventor of the SnapFast£ system, Ryan Cawood

'Lego for DNA' biotech start-up secures £150,000 of SEIS capital from Mercia

The Seed Enterprise Investment Scheme (SEIS) has allowed biotechnology business Oxford Genetics to net £150,000 of new funding.

Biomedical market: Absynth is developing vaccines to treat bacterial infections

Spin-out biomedical business gets SPARK Impact-led investment

The North West Fund for Biomedical and Fusion IP are coming together to back the growth ambition of University of Sheffield spin-out Absynth Biologics.

Medical market: Tomorrows Medicines operates in the clinical trials sector

The North West Fund for Biomedical makes 60th investment

A £250,000 investment led North West Fund for Biomedical will be used by Tomorrows Medicines to commercialise its new platform.

Software service: CliniSys produces products for clinical laboratories

ECI Partners sells CliniSys to Montagu Equity Partners to close first exit of 2013

Private equity firm ECI Partners has sold its stake in CliniSys and netted a 2.5x return on its 2007 investment.

Lower costs: ChemistDirect has taken the pharmacy online

Online pharmacy set up in garden shed dials up $10 million Atomico-led investment

Venture capital firm Atomico has stepped up to lead a $10 million investment into ChemistDirect.

Innovation: Imperial invests in tech from four universities, including Cambridge

Imperial Innovations pulls in £30 million from EIB to invest in biotech

AIM-listed investment firm Imperial Innovations Group has secured a £30 million loan so that it can make investments in the biotech and therapeutics sectors.

Sitting pretty: Beverly Lawrence was marketing director before becoming MD

NVM Private Equity backs second MBO in a week

A thirty one-year old specialist furniture business has taken on private equity backing as it looks to grow through organic and acquisitive means.

Healthcare work: Perfecus Biomed conducts microbiological testing on bacteria

Perfectus Biomed signs up two venture capital backers for infection treatment development

The £25 million North West Fund for Biomedical has made its 57th investment to date through the backing of Perfectus Biomed.

Breakthrough: Index Ventures believes the new drug could save millions of lives

Index Ventures closes its biggest life sciences investment in heart attack prevention drug

An $11 million investment from Index Ventures will be used to develop an anticoagulant drug aimed at preventing heart attacks and strokes without causing bleeding.

Medical sector: Fishawack is on its second private equity backer

Fishawack acquisition takes 12-month deal count to seven for Growth Capital Partners

Growth Capital Partners portfolio company Fishawack has completed its first acquisition since the private equity firm backed a secondary buy-out at the company back in March.

Corporate care: The incubator will be based at the Alliance Boots Beeston base

Wellness and health start-up incubator launched by Alliance Boots

A new collaboration between Alliance Boots and BioCity will see the creation of a new business incubator focused on health and wellness.

Institutional backing: TrialReach has now closed two funding rounds in two years

TrialReach adds Octopus Investments to list of investors through £2 million venture capital deal

Octopus Investments has led a £2 million investment into clinical trials platform TrialReach alongside Amadeus Capital Partners.

Medical innovation: Cerus Endovascular is tackling intracranial aneurysms

Oxford-based medical technology firm secures investment from The North West Fund for Biomedical

Cerus Endovascular is moving its operations to Liverpool Science Park following backing from The North West Fund for Biomedical.

Growth targets: Graeme Lee and Springfield are using acquisitions to expand

Investment for business growth: Springfield Healthcare Group

Care home operator Springfield Healthcare Group has already begun to use its Business Growth Fund cash to get acquisitive. We find out how progress has been since the investment as part of an exclusive portfolio roundtable.

Brain activity: Cambridge Cognition's new product is aimed at dementia detection

Dementia diagnosis firm Cambridge Cognition picks AIM to fund its growth

Neuropsychological testing business Cambridge Cognition has joined London's Alternative Investment Market.

Domiciliary care: Springfield is now hoping to grow across the North East

Springfield Homecare Services makes first Business Growth Fund-backed acquisition

Business Growth Fund portfolio company Springfield Homecare Services has closed its first acquisition since the business was supported by the bank-backed fund in June 2012.

Health services: Optimum Care provides homes and care to elderly residents

Kurt Geiger backer Graphite Capital sells Optimum Care to Terra Firma business

The private equity firm behind investments in Wagamama and Paperchase has sold its stake in Optimum Care through a trade sale.

More from GrowthBusiness

The Entrepreneur

Expert view: Business plans are the new novels, says Richard Reed

Innocent Drink’s Richard Reed on life after a $500 million company

At the beginning of 2013 Richard Reed and the rest of his founding team at Innocent Drinks sold out the last of their stake to Coca Cola. GrowthBusiness finds out what happens after exiting a business valued at $500 million.

Growing A Business

MINT nations: (Clockwise from top left) Mexico, Indonesia, Turkey and Nigeria

The emerging markets worth a MINT

Glenn Porter, general manager international identity verification at GBGroup, examines the opportunities and risks of trading with the MINT population of Mexico, Indonesia, Nigeria and Turkey.

Comment & Analysis

Is AIM's renaissance complete?

With March IPOs raising £671 million on London's AIM market, it looks like the junior exchange is back to its best.

Research

Directors' Pay on AIM 2014

The most complete review of directors' remuneration on AIM.